Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cardiovascular safety of antipsychotics: a clinical overview
Christoffer Polcwiartek, Kristian Kragholm, Ole Schjerning, et al.
Expert Opinion on Drug Safety (2016) Vol. 15, Iss. 5, pp. 679-688
Closed Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Severe mental illness: cardiovascular risk assessment and management
Christoffer Polcwiartek, Kevin O’Gallagher, Daniel J. Friedman, et al.
European Heart Journal (2024) Vol. 45, Iss. 12, pp. 987-997
Open Access | Times Cited: 22
Adverse cardiac events in out‐patients initiating clozapine treatment: a nationwide register‐based study
Christopher Rohde, Christoffer Polcwiartek, Kristian Kragholm, et al.
Acta Psychiatrica Scandinavica (2017) Vol. 137, Iss. 1, pp. 47-53
Closed Access | Times Cited: 66
Standard versus reduced dose of antipsychotics for relapse prevention in multi-episode schizophrenia: a systematic review and meta-analysis of randomised controlled trials
Mikkel Højlund, Adam F. Kemp, Peter Haddad, et al.
The Lancet Psychiatry (2021) Vol. 8, Iss. 6, pp. 471-486
Open Access | Times Cited: 51
Trends in utilization and dosing of antipsychotic drugs in Scandinavia: Comparison of 2006 and 2016
Mikkel Højlund, Anton Pottegård, Erik Johnsen, et al.
British Journal of Clinical Pharmacology (2019) Vol. 85, Iss. 7, pp. 1598-1606
Open Access | Times Cited: 47
Antipsychotics cardiotoxicity: What's known and what's next
Xiaoqing Li, Xinru Tang, Liliang Li
World Journal of Psychiatry (2021) Vol. 11, Iss. 10, pp. 736-753
Open Access | Times Cited: 34
Psychological and Psychopharmacological Interventions in Psychocardiology
Kai G. Kahl, Britta Stapel, Christoph U. Correll
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 25
Effects of psychopharmacological treatment with antipsychotic drugs on the vascular system
Kai G. Kahl, Mechthild Westhoff‐Bleck, Tillmann H. C. Krüger
Vascular Pharmacology (2017) Vol. 100, pp. 20-25
Closed Access | Times Cited: 40
Diabetic ketoacidosis in patients exposed to antipsychotics: a systematic literature review and analysis of Danish adverse drug event reports
Christoffer Polcwiartek, Torkel Vang, Christina Hedegård Bruhn, et al.
Psychopharmacology (2016) Vol. 233, Iss. 21-22, pp. 3663-3672
Closed Access | Times Cited: 36
Management of serious cardiac adverse effects of antipsychotic medications
Steven C. Stoner
Mental Health Clinician (2017) Vol. 7, Iss. 6, pp. 246-254
Open Access | Times Cited: 35
High-Throughput Chemical Screening and Structure-Based Models to Predict hERG Inhibition
Shagun Krishna, Alexandre Borrel, Ruili Huang, et al.
Biology (2022) Vol. 11, Iss. 2, pp. 209-209
Open Access | Times Cited: 17
Clinical Heart Failure Among Patients With and Without Severe Mental Illness and the Association With Long-Term Outcomes
Christoffer Polcwiartek, Daniel Loewenstein, Daniel J. Friedman, et al.
Circulation Heart Failure (2021) Vol. 14, Iss. 10
Open Access | Times Cited: 21
Drug-induced life-threatening arrhythmias and sudden cardiac death: A clinical perspective of long QT, short QT and Brugada syndromes
Diogo Ramalho, João Freitas
Revista Portuguesa de Cardiologia (2018) Vol. 37, Iss. 5, pp. 435-446
Open Access | Times Cited: 26
Cardiovascular Safety of Psychiatric Agents: A Cautionary Tale
Theodora A. Manolis, Antonis A. Manolis, Antonis S. Manolis
Angiology (2018) Vol. 70, Iss. 2, pp. 103-129
Closed Access | Times Cited: 25
Association of Bipolar Disorder With Major Adverse Cardiovascular Events: A Population-Based Historical Cohort Study
Moein Foroughi, José R. Medina‐Inojosa, Francisco López-Jiménez, et al.
Psychosomatic Medicine (2021) Vol. 84, Iss. 1, pp. 97-103
Open Access | Times Cited: 19
Direct and indirect effects of psychopharmacological treatment on the cardiovascular system
Kai G. Kahl
Hormone Molecular Biology and Clinical Investigation (2018) Vol. 36, Iss. 1
Closed Access | Times Cited: 21
Second-generation antipsychotics induce cardiotoxicity by disrupting spliceosome signaling: Implications from proteomic and transcriptomic analyses
Jing Wang, Xiaoqing Li, Zheng Liu, et al.
Pharmacological Research (2021) Vol. 170, pp. 105714-105714
Closed Access | Times Cited: 17
Diabetic ketoacidosis and diabetes associated with antipsychotic exposure among a previously diabetes-naive population with schizophrenia: a nationwide nested case–control study
Christoffer Polcwiartek, Kristian Kragholm, Christopher Rohde, et al.
Diabetologia (2017) Vol. 60, Iss. 9, pp. 1678-1690
Open Access | Times Cited: 20
Myocardial infarction risk and antipsychotics use revisited: a meta-analysis of 10 observational studies
Kai‐Lin Huang, Ching‐Ju Fang, Chien‐Chi Hsu, et al.
Journal of Psychopharmacology (2017) Vol. 31, Iss. 12, pp. 1544-1555
Open Access | Times Cited: 20
Electrocardiogram Characteristics and Their Association With Psychotropic Drugs Among Patients With Schizophrenia
Christoffer Polcwiartek, Kristian Kragholm, Steen Møller Hansen, et al.
Schizophrenia Bulletin (2019)
Open Access | Times Cited: 19
MENTAL DISORDERS AND CARDIOVASCULAR DISEASES: GUIDELINES OF THE BAIKAL PSYCHOSOMATIC ASSOCIATION AND THE SIBERIAN PSYCHOSOMATIC ASSOCIATION
Belialov Fi, А. Н. Сумин, Н. П. Гарганеева, et al.
Complex Issues of Cardiovascular Diseases (2024) Vol. 13, Iss. 3S, pp. 222-253
Closed Access | Times Cited: 1
Atypical antipsychotics and oxidative cardiotoxicity: review of literature and future perspectives to prevent sudden cardiac death.
Stefano D’Errico, Raffaele La Russa, Aniello Maiese, et al.
Journal of Geriatric Cardiology (2021) Vol. 18, Iss. 8, pp. 663-685
Closed Access | Times Cited: 10
Delirium in hemodialysis predicts mortality: a single-center, long-term observational study
Norio Yasui‐Furukori, Natsumi Tarakita, Waka Uematsu, et al.
Neuropsychiatric Disease and Treatment (2017) Vol. Volume 13, pp. 3011-3016
Open Access | Times Cited: 10
Pathogenesis and management of Brugada syndrome in schizophrenia: A scoping review
Anuj Rastogi, Dylan Viani-Walsh, Shareef Akbari, et al.
General Hospital Psychiatry (2020) Vol. 67, pp. 83-91
Open Access | Times Cited: 10
Drug-induced life-threatening arrhythmias and sudden cardiac death: A clinical perspective of long QT, short QT and Brugada syndromes
Diogo Ramalho, João Freitas
Revista Portuguesa de Cardiologia (English Edition) (2018) Vol. 37, Iss. 5, pp. 435-446
Open Access | Times Cited: 10
Changing the treatment paradigm for Parkinson’s disease psychosis with pimavanserin
Kelly E. Lyons, Rajesh Pahwa, Neal Hermanowicz, et al.
Expert Review of Clinical Pharmacology (2019) Vol. 12, Iss. 7, pp. 681-691
Closed Access | Times Cited: 8
Page 1 - Next Page

Scroll to top